Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20180711002
TCTR20180711002
Unknown
Phase 3

A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial

Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy0 sites90 target enrollmentJuly 11, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions&#45This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron&#45RF8radiation therapychemotherapy

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
&#45
Sponsor
Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy
Enrollment
90
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 11, 2018
End Date
June 30, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy

Eligibility Criteria

Inclusion Criteria

  • •\- CA cervix FIGO stage IB2, IIA2\-IVA
  • •\- Patho : squamous cell carcinoma, adenosquamous carcinoma or adenocarcinoma
  • •\- Age more than 18 years
  • •\- KPS \> 70
  • •\- Treatment plan is concurrent chemoradiotherapy
  • •\- No paraaortic lymph node metastasis
  • •\- Adequate bone marrow and kidney function
  • •\- No HIV history

Exclusion Criteria

  • •\- Patients have cardiac pacemaker or metal prosthesis in their body
  • •\- Patients received abdominal radiotherapy or chemotherapy
  • •\- Distant metastases
  • •\- Previous malignancy, except adequately treated non\-melanoma skin cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 2
Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomas
JPRN-UMIN000023416agoya University Graduate School of Medicine, Department of Radiology40
Completed
N/A
Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancerlocally advenced tongue cancer
JPRN-UMIN000032732Department of radiation oncology, Southern Tohoku Proton Therapy Center30
Withdrawn
N/A
A Phase II Study of concurrent chemo-radiotherapy with Gemcitabine followed by chemotherapy with Gemcitabine and Cisplatin for unresectable localized perihilar cholangiocarcinomaNeoplasms
KCT0003478CC Hospital27
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canal
JPRN-UMIN000012184Japanese Radiation Oncology Study Group40
Completed
Phase 1
A phase I/II study of concurrent chemoradiotherapy (RT-DeVIC) for newly-diagnosed, localized nasal NK/T-cell lymphoma (JCOG0211-DI)extranodal NK/T-cell lymphoma, nasal type
JPRN-UMIN000007842Japan Clinical Oncology Group (JCOG)33